Detalhe da pesquisa
1.
Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study.
Br J Haematol
; 204(5): 1740-1751, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351734
2.
Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event-A population based cohort study.
Eur J Haematol
; 110(6): 608-617, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725666
3.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
4.
Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN group.
Eur J Haematol
; 109(4): 336-342, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696444
5.
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
Br J Haematol
; 189(5): 913-919, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066200
6.
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up.
Eur J Haematol
; 104(3): 271-278, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863513
7.
Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group.
Eur J Haematol
; 102(3): 235-240, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472746
8.
Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms.
Eur J Haematol
; 100(5): 419-425, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369421
9.
A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera.
Br J Haematol
; 177(5): 800-805, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474342
10.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Haematologica
; 102(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540137
11.
Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry.
Eur J Haematol
; 98(6): 577-583, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251679
12.
The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Cancer
; 122(12): 1888-96, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070130
13.
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients.
Blood
; 123(24): 3803-10, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553173
14.
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.
Blood
; 124(7): 1183-91, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24963042
15.
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
Haematologica
; 101(8): 926-31, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27175028
16.
Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.
Eur J Haematol
; 94(2): 152-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039361
17.
Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.
Br J Haematol
; 160(2): 251-4, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151052
18.
A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.
Br J Haematol
; 162(4): 498-508, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23758082
19.
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.
Blood
; 118(2): 401-8, 2011 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21536863
20.
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.
Front Oncol
; 13: 1190305, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637067